Relationship between inflammatory markers and new cardiovascular events in patients with acute myocardial infarction who underwent primary angioplasty
- PMID: 23777720
- PMCID: PMC4776816
- DOI: 10.5539/gjhs.v5n4p48
Relationship between inflammatory markers and new cardiovascular events in patients with acute myocardial infarction who underwent primary angioplasty
Abstract
Introduction: The determination of inflammation markers in circulation has enabled an important improvement in the study of cardiovascular diseases. It was tested the hypothesis that non-specific markers such as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and fibrinogen may provide prognostic information in patients with acute myocardial infarction with persistent ST-segment elevation (STEMI) undergoing primary angioplasty (PCI).
Patients: A cohort of 197 consecutive patients with STEMI undergoing primary PCI was enrolled, evaluating during hospitalization, the peak values of the following markers of inflammation: ESR, CRP and fibrinogen. A telephone follow-up has been made in order to investigate any possible new cardiovascular events after hospital discharge and the procedure performed.
Results: Higher values of CRP were statistically associated with adverse future events as composite endpoint and with the single endpoint of death. Furthermore, higher age, presence of hypertension, history of previous cardiovascular events, were statistically significantly associated with cardiac events at follow up. In this group were also overrepresented subjects with anterior myocardial infarction in the anterior localization and with an EF ? 35% at discharge.
Conclusions: CRP appears to be a predictor of future cardiovascular events, confirming that a pro-inflammatory state promotes the progression of atherosclerotic disease and its complications.
Similar articles
-
Diagnostic value of biohumoral markers of necrosis and inflammation in patients with right ventricular myocardial infarction.Prilozi. 2007 Jul;28(1):23-38. Prilozi. 2007. PMID: 17921916
-
Fibrinogen and C-reactive protein on admission as markers of final infarct size after primary angioplasty for acute myocardial infarction.Atherosclerosis. 2001 Jul;157(1):189-96. doi: 10.1016/s0021-9150(00)00703-6. Atherosclerosis. 2001. PMID: 11427220
-
[Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].An Med Interna. 2002 Jun;19(6):283-8. An Med Interna. 2002. PMID: 12152386 Spanish.
-
Blunted inflammatory response in STEMI patients timely reperfused.J Cardiovasc Med (Hagerstown). 2014 Jan;15(1):48-52. doi: 10.2459/JCM.0b013e328365c13a. J Cardiovasc Med (Hagerstown). 2014. PMID: 24492356
-
[The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].Turk Kardiyol Dern Ars. 2009 Jan;37(1):19-25. Turk Kardiyol Dern Ars. 2009. PMID: 19225249 Turkish.
Cited by
-
Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association.Circulation. 2016 Mar 29;133(13):1302-31. doi: 10.1161/CIR.0000000000000381. Epub 2016 Feb 29. Circulation. 2016. PMID: 26927362 Free PMC article. Review. No abstract available.
-
Efficacy and safety of eight types Salvia miltiorrhiza injections in the treatment of unstable angina pectoris: A network meta-analysis.Front Pharmacol. 2022 Oct 3;13:972738. doi: 10.3389/fphar.2022.972738. eCollection 2022. Front Pharmacol. 2022. PMID: 36263128 Free PMC article.
-
Upper body fat predicts metabolic syndrome similarly in men and women.Eur J Clin Invest. 2018 Jul;48(7):e12941. doi: 10.1111/eci.12941. Epub 2018 May 15. Eur J Clin Invest. 2018. PMID: 29682733 Free PMC article.
References
-
- Albert C. M., Ma J, Rifai N, Stampfer M. J., Ridker P. M. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation. 2002;105(22):2595–2599. - PubMed
-
- Albert M. A., Danielson E, Rifai N, Ridker P. M. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001;286(1):64–70. - PubMed
-
- Birnbaum Y, Ye Y. Pleiotropic effects of statins: the role of eicosanoid production. Curr Atheroscler Rep. 2012;14(2):135–139. http://dx.doi.org/10.1007/s11883-012-0232-5 . - PubMed
-
- Bonow R. O., Mann D. L., Zipes D. P., Libby P. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set. Elsevier Health Sciences; 2011.
-
- Coppola G, Corrado E, Muratori I, Tantillo R, Vitale G, Lo Coco L, Novo S. Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM. Int JCardiol. 2006;106(1):16–20. http://dx.doi.org/10.1016/j.ijcard.2004.12.051 . - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous